Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug conjugate (ADC) ...

PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug ...

Nanocarriers have emerged as powerful tools in cancer therapy, offering targeted, efficient, and minimally invasive treatment ...

Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which ...

In mouse models of lung and skin cancer, adding sucralose to the diet made anti-PD1 immunotherapy less effective, resulting ...

After damage, lysosomes undergo extensive ubiquitylation that helps restore lysosomal function. ATXN3 with its partner p97 ...

People who consume some artificial sweeteners are less likely to respond to certain cancer therapies, potentially because of ...

Less than one packet of the sweetener a day could be enough to shift the gut microbiome and negatively impact immunotherapy.

UChicago researchers have developed a new blood test that uses RNA modifications to detect early-stage colorectal cancer with ...

Patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose had worse response to ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.